Incidence of cancer after immunosuppressive treatment for heart transplantation

Giovanbattista Ippoliti, Mauro Rinaldi, Carlo Pellegrini, Mario Viganò

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Prolonged or intensive immunosuppressive therapy used after organ transplantation is complicated by an increased incidence of cancer. Striking differences in incidence are observed in heart and heart-lung transplant recipients when compared with renal transplant patients. The most significant increase was in the incidence of lymphomas in cardiac versus renal patients. Moreover, a two-fold greater increase of all neoplasms was found in cardiac recipients, with nearly a six-fold increase in visceral tumors. Several factors may account for these differences. In cardiac allograft recipients, intensive immunosuppression is frequently used to reverse acute rejection and the highest number of cardiac transplants was performed in the era of polypharmacy, usually consisting of triple therapy.

Original languageEnglish
Pages (from-to)101-113
Number of pages13
JournalCritical Reviews in Oncology/Hematology
Volume56
Issue number1 SPEC. ISS.
DOIs
Publication statusPublished - Oct 2005

Fingerprint

Heart Transplantation
Immunosuppressive Agents
Incidence
Transplants
Kidney
Polypharmacy
Neoplasms
Organ Transplantation
Immunosuppression
Allografts
Lymphoma
Therapeutics
Lung

Keywords

  • Acute rejection
  • Immunosuppression
  • Infection
  • Lymphoma
  • Risk factor
  • Solid tumor

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Incidence of cancer after immunosuppressive treatment for heart transplantation. / Ippoliti, Giovanbattista; Rinaldi, Mauro; Pellegrini, Carlo; Viganò, Mario.

In: Critical Reviews in Oncology/Hematology, Vol. 56, No. 1 SPEC. ISS., 10.2005, p. 101-113.

Research output: Contribution to journalArticle

Ippoliti, Giovanbattista ; Rinaldi, Mauro ; Pellegrini, Carlo ; Viganò, Mario. / Incidence of cancer after immunosuppressive treatment for heart transplantation. In: Critical Reviews in Oncology/Hematology. 2005 ; Vol. 56, No. 1 SPEC. ISS. pp. 101-113.
@article{316de960be9f44c6977012ef3b4458dc,
title = "Incidence of cancer after immunosuppressive treatment for heart transplantation",
abstract = "Prolonged or intensive immunosuppressive therapy used after organ transplantation is complicated by an increased incidence of cancer. Striking differences in incidence are observed in heart and heart-lung transplant recipients when compared with renal transplant patients. The most significant increase was in the incidence of lymphomas in cardiac versus renal patients. Moreover, a two-fold greater increase of all neoplasms was found in cardiac recipients, with nearly a six-fold increase in visceral tumors. Several factors may account for these differences. In cardiac allograft recipients, intensive immunosuppression is frequently used to reverse acute rejection and the highest number of cardiac transplants was performed in the era of polypharmacy, usually consisting of triple therapy.",
keywords = "Acute rejection, Immunosuppression, Infection, Lymphoma, Risk factor, Solid tumor",
author = "Giovanbattista Ippoliti and Mauro Rinaldi and Carlo Pellegrini and Mario Vigan{\`o}",
year = "2005",
month = "10",
doi = "10.1016/j.critrevonc.2005.03.013",
language = "English",
volume = "56",
pages = "101--113",
journal = "Critical Reviews in Oncology/Hematology",
issn = "1040-8428",
publisher = "Elsevier Ireland Ltd",
number = "1 SPEC. ISS.",

}

TY - JOUR

T1 - Incidence of cancer after immunosuppressive treatment for heart transplantation

AU - Ippoliti, Giovanbattista

AU - Rinaldi, Mauro

AU - Pellegrini, Carlo

AU - Viganò, Mario

PY - 2005/10

Y1 - 2005/10

N2 - Prolonged or intensive immunosuppressive therapy used after organ transplantation is complicated by an increased incidence of cancer. Striking differences in incidence are observed in heart and heart-lung transplant recipients when compared with renal transplant patients. The most significant increase was in the incidence of lymphomas in cardiac versus renal patients. Moreover, a two-fold greater increase of all neoplasms was found in cardiac recipients, with nearly a six-fold increase in visceral tumors. Several factors may account for these differences. In cardiac allograft recipients, intensive immunosuppression is frequently used to reverse acute rejection and the highest number of cardiac transplants was performed in the era of polypharmacy, usually consisting of triple therapy.

AB - Prolonged or intensive immunosuppressive therapy used after organ transplantation is complicated by an increased incidence of cancer. Striking differences in incidence are observed in heart and heart-lung transplant recipients when compared with renal transplant patients. The most significant increase was in the incidence of lymphomas in cardiac versus renal patients. Moreover, a two-fold greater increase of all neoplasms was found in cardiac recipients, with nearly a six-fold increase in visceral tumors. Several factors may account for these differences. In cardiac allograft recipients, intensive immunosuppression is frequently used to reverse acute rejection and the highest number of cardiac transplants was performed in the era of polypharmacy, usually consisting of triple therapy.

KW - Acute rejection

KW - Immunosuppression

KW - Infection

KW - Lymphoma

KW - Risk factor

KW - Solid tumor

UR - http://www.scopus.com/inward/record.url?scp=24644437846&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24644437846&partnerID=8YFLogxK

U2 - 10.1016/j.critrevonc.2005.03.013

DO - 10.1016/j.critrevonc.2005.03.013

M3 - Article

C2 - 15979322

AN - SCOPUS:24644437846

VL - 56

SP - 101

EP - 113

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

IS - 1 SPEC. ISS.

ER -